Clinical Trial Update: Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing an investigational drug to an approved drug in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Organon and Co | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED